Provided by Tiger Trade Technology Pte. Ltd.

Femasys Inc

0.7664
-0.0873-10.23%
Post-market: 0.80000.0336+4.38%17:23 EST
Volume:1.56M
Turnover:1.26M
Market Cap:44.82M
PE:-1.14
High:0.8536
Open:0.8500
Low:0.7600
Close:0.8537
52wk High:1.80
52wk Low:0.3067
Shares:58.48M
Float Shares:42.26M
Volume Ratio:1.53
T/O Rate:3.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6709
EPS(LYR):-0.8450
ROE:-376.23%
ROA:-69.37%
PB:9.84
PE(LYR):-0.91

Loading ...

Company Profile

Company Name:
Femasys Inc
Exchange:
NASDAQ
Establishment Date:
2004
Employees:
70
Office Location:
3950 Johns Creek Court,Suite 100,Suwanee,Georgia,United States
Zip Code:
30024
Fax:
404 581 5903
Introduction:
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

Directors

Name
Position
Charles Larsen
Chairperson and Director
Kathy Lee Sepsick
Founder, President, CEO and Director
Alistair Milnes
Director
Edward Uzialko
Director
Joshua Silverman
Director

Shareholders

Name
Position
Dov Elefant
Chief Financial Officer
Christine Thomas
Chief Regulatory and Clinical Officer
Kathy Lee Sepsick
Founder, President, CEO and Director